Suppr超能文献

大前庭神经鞘瘤的低分次立体定向放射外科治疗结果

The Outcome of Hypofractionated Stereotactic Radiosurgery for Large Vestibular Schwannomas.

作者信息

Teo Mario, Zhang Michael, Li Amy, Thompson Patricia A, Tayag Armine T, Wallach Jonathan, Gibbs Iris C, Soltys Scott G, Hancock Steven L, Chang Steven D

机构信息

Department of Neurosurgery, Stanford University School of Medicine, Stanford, California, USA.

Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California, USA.

出版信息

World Neurosurg. 2016 Sep;93:398-409. doi: 10.1016/j.wneu.2016.06.080. Epub 2016 Jun 28.

Abstract

OBJECTIVES

Stereotactic radiosurgery (SRS) for large vestibular schwannomas (VS) remains controversial. We studied the tumor local control and toxicity rates after hypofractionated SRS for VS > 3 cm.

METHODS

A total of 587 patients with VS treated with SRS between 1998 and 2014 were reviewed retrospectively, and 30 Koos grade IV VSs were identified. There were 6 patients with neurofibromatosis 2 (NF2), 8 with cystic tumors, 22 with solid tumors, 19 who underwent primary CyberKnife (CK), and 11 with >3 cm after previous resection. Patients were treated by a median of 3 fractions at 18 Gy.

RESULTS

After a median 97 months, the 3- and 10-year Kaplan-Meier estimates of local control were 85% and 80%, respectively, with 20% requiring salvage treatment. For patients who had previous tumor resection rather than primary CK, the estimates were 46% and 5%, respectively, with progression, and 3-year control rates of 71% and 94% (P = 0.008). Tumor control was also lower among NF2 versus non-NF2 patients (40% vs. 95%; P = 0.0014). Among patients with good clinical baselines before CK, 88% were functionally independent (modified Rankin Scale score, 0-2), 88% had good facial function (House-Brackmann grade I-II), and 38% had serviceable hearing (Gardner-Robertson grade I-II) at last follow-up. Hearing worsening was more likely among patients treated with primary CK (33% vs. 90%; P = 0.04).

CONCLUSIONS

Overall, 80% of large VSs were adequately controlled by CK with 97 months of median follow-up. Patients with previous surgery and NF2 also appeared to have higher rates of tumor progression, and less favorable functional outcomes.

摘要

目的

大型前庭神经鞘瘤(VS)的立体定向放射外科治疗(SRS)仍存在争议。我们研究了超分割SRS治疗直径>3 cm的VS后的肿瘤局部控制率和毒性率。

方法

回顾性分析1998年至2014年间接受SRS治疗的587例VS患者,确定30例库斯IV级VS。其中神经纤维瘤病2型(NF2)患者6例,囊性肿瘤患者8例,实性肿瘤患者22例,初次接受射波刀(CK)治疗的患者19例,既往切除术后肿瘤直径>3 cm的患者11例。患者接受中位剂量为18 Gy、分3次的治疗。

结果

中位随访97个月后,3年和10年的Kaplan-Meier局部控制估计率分别为85%和80%,20%的患者需要挽救治疗。对于既往接受过肿瘤切除术而非初次CK治疗的患者,进展后的估计率分别为46%和5%,3年控制率分别为71%和94%(P = 0.008)。NF2患者与非NF2患者相比,肿瘤控制率也较低(40%对95%;P = 0.0014)。在CK治疗前临床基线良好的患者中,末次随访时88%功能独立(改良Rankin量表评分,0 - 2),88%面部功能良好(House-Brackmann分级I - II级),3次8%听力尚可(Gardner-Robertson分级I - II级)。初次接受CK治疗的患者听力恶化的可能性更大(33%对90%;P = 0.04)。

结论

总体而言,中位随访97个月时,80%的大型VS通过CK得到了充分控制。既往接受过手术的患者和NF2患者似乎也有较高的肿瘤进展率和较差的功能结局。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验